Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4970 publications
From ethanol to propylene glycol: A safer future for carmustine.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: October 16, 2025
Analysis of Anticancer Drugs Used to Treat Brain Cancer Using the Cheapest and Costliest Drugs in India: A Cost-comparison Health Economics Study.
Journal: The Journal of the Association of Physicians of India
Published: October 16, 2025
Ex Vivo and In Vivo Evaluation of an In Situ Nanogel Composite loaded with Carmustine: Implications for efficient nose-to-brain delivery.
Journal: Pharmaceutical development and technology
Published: September 23, 2025
An Update on Alkylating Agents in Breast Cancer Therapy.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: September 17, 2025
Carmustine Wafers (Gliadel) in Brain Metastases: Revisiting an Old Concept With New Insights.
Journal: Cureus
Published: August 29, 2025
Investigation of Host-Guest Inclusion Complexes Between Carmustine and α-Cyclodextrin: Synthesis, Characterization, and Evaluation.
Journal: International journal of molecular sciences
Published: August 28, 2025
"B" symptoms and CBV conditioning negatively impact survival in mantle cell lymphoma patients undergoing autologous stem cell transplantation.
Journal: Annals of hematology
Published: July 28, 2025
Overall survival after carmustine wafers implantation for newly-diagnosed high grade glioma. A nationwide population-based controlled propensity score-matched analysis.
Journal: Clinical neurology and neurosurgery
Published: July 22, 2025
Incidence and Outcomes of Neutropenic Enterocolitis Post-stem Cell Transplant for Hematological Malignancies: A Retrospective Study in Australia.
Journal: Cureus
Published: July 08, 2025
Electrospun PMVEMA Nanofibers Developed as a Fast-Release Platform for Antineoplastic Drugs Tested in Glioblastoma Primary Cultures.
Journal: Pharmaceutics
Published: July 07, 2025
Last Updated: 10/31/2025